Michael Schmanske

Michael Schmanske is a New York-based solo angel writing $25K to $100K at pre-seed and seed into digital health and health IT software. Public data is limited to a LinkedIn profile, with no website, Twitter, or Crunchbase footprint listed, so founders should expect a personal-relationship angel rather than an institutional vehicle. The New York base places him in the densest provider, payer, and digital health investor cluster in the country, which is where his network and value-add are most concentrated. AI is not flagged as a focus, so model-first pitches without a clear workflow or buyer wedge will be a weaker fit. Check size positions him as a single-conviction angel suited to syndicate participation rather than a round leader, with highest value as an early signal investor and downstream-introduction broker into New York healthcare buyers and Series A funds. Founders most likely to convert are early digital health and health IT teams with a working prototype, an identified buyer in providers or payers, and a clear early-revenue or pilot wedge. Biotech, devices, life sciences tools, and consumer wellness are weaker matches given the stated verticals. The entry path is a LinkedIn message, ideally warmed by a mutual New York healthcare or fintech connection, leading with the operational problem, the specific buyer, and the precise reason an angel check accelerates the next milestone. Without a warm intro, expect a low response rate; with one, the conversation tends to move at angel speed.